DeepMind, an artificial intelligence company owned by Google, plans to develop a medical product.
It will help doctors to detect more than 50 sight-threatening conditions from a common type of eye scan.
The artificial intelligence software can detect signs of disease better than human doctors, according to a study published Monday in the scientific journal Nature Medicine.
The company and its partners in the research, London’s Moorfields Eye Hospital and the University College London Institute of Ophthalmology, said will go for clinical trials of the technology in 2019.
If proved successful, DeepMind will seek to create a regulator-approved product that Moorfields could roll out across the UK.
This is the first time, DeepMind AI algorithm using machine learning has ended up in a healthcare product.
Earlier this year, Verily, an Alphabet-owned life sciences company, worked with AI experts from Google to develop an algorithm that could spot a range of cardiovascular issues from a different retinal image.